Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety, Tolerability and Immunologic Noninferiority of a 13-valent Pneumococcal Conjugate Vaccine Compared to a 7-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in the United States
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of the 13-valent pneumococcal vaccine (13vPnC) compare to the 7-valent pneumococcal vaccine (7vPnC) and to compare the immune response to concomitant vaccines administered with 13vPnC and 7vPnC.


Options:
A: Arm Label: 13vPnC vaccine; Type: EXPERIMENTAL; Interventions: Biological: 13 valent pneumococcal conjugate vaccine | Arm Label: 7vPnC vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: 7vPnc pneumococcal conjugate vaccine | Intervention Type: BIOLOGICAL; Name: 13 valent pneumococcal conjugate vaccine; Assigned to Arm(s): 13vPnC vaccine | Intervention Type: BIOLOGICAL; Name: 7vPnc pneumococcal conjugate vaccine; Assigned to Arm(s): 7vPnC vaccine
B: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: FluMist | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: FluMist | Intervention Type: BIOLOGICAL; Name: FluMist; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: FluMist; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): 3
C: Intervention Type: BIOLOGICAL; Name: MMRV; Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: MMR (Priorix®); Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Varicella (Varilrix®); Assigned to Arm(s): N/A
D: Arm Label: Menhibrix A Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix B Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix C Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: ActHIB Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: ActHIB, Biological: PedvaxHIB | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: ActHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: PedvaxHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: Pediarix; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Prevnar; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: M-M-R II; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Varivax; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group

Answer: A